BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17996038)

  • 21. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.
    Mota P; Silva HC; Soares MJ; Pego A; Loureiro M; Cordeiro CR; Regateiro FJ
    J Cancer Res Clin Oncol; 2015 May; 141(5):851-60. PubMed ID: 25388590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
    Costa GN; Magno LA; Santana CV; Konstantinovas C; Saito ST; Machado M; Di Pietro G; Bastos-Rodrigues L; Miranda DM; De Marco LA; Romano-Silva MA; Rios-Santos F
    Mol Diagn Ther; 2012 Aug; 16(4):241-50. PubMed ID: 22788240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes.
    Buch SC; Nazar-Stewart V; Weissfeld JL; Romkes M
    Head Neck; 2008 Sep; 30(9):1139-47. PubMed ID: 18642288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population.
    Wang J; Deng Y; Li L; Kuriki K; Ding J; Pan X; Zhuge X; Jiang J; Luo C; Lin P; Tokudome S
    Cancer Sci; 2003 May; 94(5):448-52. PubMed ID: 12824892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis.
    Sun F; Chen Y; Xiang Y; Zhan S
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):994-1002. PubMed ID: 18713495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people.
    Quiñones L; Lucas D; Godoy J; Cáceres D; Berthou F; Varela N; Lee K; Acevedo C; Martínez L; Aguilera AM; Gil L
    Cancer Lett; 2001 Dec; 174(1):35-44. PubMed ID: 11675150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility.
    Luo YP; Chen HC; Khan MA; Chen FZ; Wan XX; Tan B; Ou-Yang FD; Zhang DZ
    Tumour Biol; 2011 Feb; 32(1):215-22. PubMed ID: 20878561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M; Michaud D; De Vivo I
    BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma.
    Morita S; Yano M; Tsujinaka T; Akiyama Y; Taniguchi M; Kaneko K; Miki H; Fujii T; Yoshino K; Kusuoka H; Monden M
    Int J Cancer; 1999 Mar; 80(5):685-8. PubMed ID: 10048967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population.
    Sreeja L; Syamala V; Hariharan S; Madhavan J; Devan SC; Ankathil R
    J Hum Genet; 2005; 50(12):618-27. PubMed ID: 16228113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of genetic polymorphisms of
    Yang S; Hwang SJ; Park JY; Chung EK; Lee JI
    BMJ Open; 2019 Aug; 9(8):e027940. PubMed ID: 31375612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: a case-control study.
    Cai L; Yu SZ; Zhang ZF
    World J Gastroenterol; 2001 Aug; 7(4):506-9. PubMed ID: 11819818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
    Wu MS; Chen CJ; Lin MT; Wang HP; Shun CT; Sheu JC; Lin JT
    Int J Colorectal Dis; 2002 Sep; 17(5):338-43. PubMed ID: 12172927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
    Olivieri EH; da Silva SD; Mendonça FF; Urata YN; Vidal DO; Faria Mde A; Nishimoto IN; Rainho CA; Kowalski LP; Rogatto SR
    Oral Oncol; 2009 Sep; 45(9):e73-9. PubMed ID: 19442564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
    Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S
    Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Allelic variants of cytochrome P4501A1 (CYP1A1), glutathione S transferase M1 (GSTM1) polymorphisms and their association with smoking and alcohol consumption as gastric cancer susceptibility biomarkers].
    Lee K; Cáceres D; Varela N; Csendes D A; Ríos R H; Quiñones S L
    Rev Med Chil; 2006 Sep; 134(9):1107-15. PubMed ID: 17171211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of CYP2E1 and NAT2 polymorphisms with lung cancer susceptibility among Mongolian and Han populations in the Inner Mongolian region.
    Zhang JW; Yu WJ; Sheng XM; Chang FH; Bai TY; Lv XL; Wang G; Liu SZ
    Asian Pac J Cancer Prev; 2014; 15(21):9203-10. PubMed ID: 25422202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility: a case-control study in a Han nationality population in Southern China.
    Yang J; Qian LX; Wu HF; Xu ZQ; Sui YG; Wang XR; Zhang W
    Int J Urol; 2006 Jun; 13(6):773-80. PubMed ID: 16834659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
    Singla N; Gupta D; Birbian N; Singh J
    Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking.
    Yoshida K; Osawa K; Kasahara M; Miyaishi A; Nakanishi K; Hayamizu S; Osawa Y; Tsutou A; Tabuchi Y; Shimada E; Tanaka K; Yamamoto M; Takahashi J
    Asian Pac J Cancer Prev; 2007; 8(3):438-44. PubMed ID: 18159984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.